Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Cost Management Should Emphasize Generics Over Rebates - BC/BS Exec

Executive Summary

The goal for pharmacy managers should be a decline in drug budgets over the next few years in light of patent expirations, Regence Blue Shield of Idaho Assistant VP-Pharmacy Services Terrance Killilea told the Pharmaceutical Benefit Management Institute April 28 in Scottsdale, Ariz.

You may also be interested in...



PBM Standards Allow Preparation Of Formulary Reviews For P&T Committee

Pharmacy benefit management standards developed by the trade association PCMA allow PBMs to provide an initial formulary review to an independent pharmacy and therapeutics committee.

PBM Standards Allow Preparation Of Formulary Reviews For P&T Committee

Pharmacy benefit management standards developed by the trade association PCMA allow PBMs to provide an initial formulary review to an independent pharmacy and therapeutics committee.

Amgen's Kineret Arthritis Product Being Watched By Medco For Cost Impact

Merck-Medco anticipates FDA approval for Amgen's rheumatoid arthritis treatment Kineret as early as the first quarter of 2001. The PBM is keeping close track of development of the drug as one of a handful of R&D projects that could have a significant impact on drug spending when they reach the market.

Related Content

UsernamePublicRestriction

Register

LL1126093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel